Brooks Automation, Inc (NASDAQ:BRKS) has been downgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: January 11, 2017
Boasting a price of $17.21, Brooks Automation, Inc (NASDAQ:BRKS) traded 1.28% higher on the day. The last stock close price is up 26.88% from the 200-day moving average, compared to the S&P 500 which has decreased -0.05% over the same time. The company has recorded a 50-day moving average of $16.68 and a two hundred day average of $13.74. Volume of trade was down over the average, with 360,662 shares of BRKS changing hands under the typical 421,513
Zacks Investment Research has downgraded Brooks Automation, Inc (NASDAQ:BRKS) to Hold in a statement released on Wednesday January 11, 2017.
See Chart Below
Brooks Automation, Inc has a 52 week low of $8.33 and a 52 week high of $17.98 The company’s market cap is currently $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 4 brokers have issued a research note on the company. The average stock price target is $13.45 with 1 broker rating the stock a strong buy, 2 brokers rating the stock a buy, 1 broker rating the stock a hold, 1 broker rating the stock a underperform, and finally 0 brokers rating the stock a sell.
General Information About Brooks Automation, Inc (NASDAQ:BRKS)
Brooks Automation, Inc. is a provider of automation and cryogenic solutions for various applications and markets. The Company operates through two segments: Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum and contamination controls solutions and services. Its product offerings include robots and integrated automation systems for handling of substrates. It is also a provider of cryogenic components to create vacuum and thermal stability within critical operating environments in the manufacturing process. It also offers equipment for automated contamination control, conditioning and metrology solutions for wafer and reticle carriers. The Brooks Life Science Systems segment offers sample life cycle management solutions that provide life science and bioscience customers with a range of sample management solutions for scientific research and support drug development.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.